Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 3 Brain Neoplasms 3 Radiation Pneumonitis 1 Radiation Injuries 1 Prostatic Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Optic Neuritis 1 Neoplasms, Fibrous Tissue 1 Neoplasms, Connective and Soft Tissue 1 Neoplasms, Connective Tissue 1 Neoplasms by Histologic Type 1 Neoplasm Metastasis 1 Myelitis, Transverse 1 Myelitis 1 Myasthenia Gravis 1 Musculoskeletal Diseases 1 Lung Neoplasms 1 Lung Diseases, Interstitial 1 Joint Diseases 1 Glioma 1 Fibroma 1 Dupuytren Contracture 1 Contracture 1 Connective Tissue Diseases 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

fludarabine 6 efgartigimod alfa 6 Cyclophosphamide 6 ravulizumab 4 zilucoplan 2 telitacicept 2 rozanolixizumab 2 Prednisone 2 remibrutinib 1 iptacopan 1 inebilizumab 1 bu-zhong-yi-qi-tang 1 Walk Test 1 Tacrolimus 1 Steroids 1 Rituximab 1 Pyridostigmine Bromide 1 Prednisolone 1 Mycophenolic Acid 1 Diagnostic Self Evaluation 1 Cognitive Behavioral Therapy 1 Cladribine 1 Biomarkers 1 Azathioprine 1 Alleles 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Myasthenia Gravis × Adrenal Cortex Hormones × Clear all

NCT06342544 2026-01-21

IMCOMG

Fondation Ophtalmologique Adolphe de Rothschild

Phase 3 Recruiting

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡